The potential of encapsulating “raw materials” in 3D osteochondral gradient scaffolds

Scaffolds with continuous gradients in material composition and bioactive signals enable a smooth transition of properties at the interface. Components like chondroitin sulfate (CS) and bioactive glass (BG) in 3D scaffolds may serve as “raw materials” for synthesis of new extracellular matrix (ECM), and may have the potential to completely or partially replace expensive growth factors. We hypothesized that scaffolds with gradients of ECM components would enable superior performance of engineered constructs. Raw material encapsulation altered the appearance, structure, porosity, and degradation of the scaffolds. They allowed the scaffolds to better retain their 3D structure during culture and provided a buffering effect to the cells in culture. Following seeding of rat mesenchymal stem cells, there were several instances where glycosaminoglycan (GAG), collagen, or calcium contents were higher with the scaffolds containing raw materials (CS or BG) than with those containing transforming growth factor (TGF)‐β3 or bone morphogenetic protein (BMP)‐2. It was also noteworthy that a combination of both CS and TGF‐β3 increased the secretion of collagen type II. Moreover, cells seeded in scaffolds containing opposing gradients of CS/TGF‐β3 and BG/BMP‐2 produced clear regional variations in the secretion of tissue‐specific ECM. The study demonstrated raw materials have the potential to create a favorable microenvironment for cells; they can significantly enhance the synthesis of certain extracellular matrix (ECM) components when compared to expensive growth factors; either alone or in combination with growth factors they can enhance the secretion of tissue specific matrix proteins. Raw materials are promising candidates that can be used to either replace or be used in combination with growth factors. Success with raw materials in lieu of growth factors could have profound implications in terms of lower cost and faster regulatory approval for more rapid translation of regenerative medicine products to the clinic. Biotechnol. Bioeng. 2014;111: 829–841. © 2013 Wiley Periodicals, Inc.

[1]  Aaron M. Scurto,et al.  Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres. , 2013, Materials science & engineering. C, Materials for biological applications.

[2]  Michael S Detamore,et al.  Leveraging "raw materials" as building blocks and bioactive signals in regenerative medicine. , 2012, Tissue engineering. Part B, Reviews.

[3]  Neethu Mohan,et al.  Continuous gradients of material composition and growth factors for effective regeneration of the osteochondral interface. , 2011, Tissue engineering. Part A.

[4]  M. Detamore,et al.  Osteochondral interface regeneration of rabbit mandibular condyle with bioactive signal gradients. , 2011, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[5]  Delbert E Day,et al.  Bioactive glass in tissue engineering. , 2011, Acta biomaterialia.

[6]  Aldo R Boccaccini,et al.  A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. , 2011, Biomaterials.

[7]  Q. Fu,et al.  Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation. , 2010, Journal of biomedical materials research. Part A.

[8]  Keiichi Kuroki,et al.  Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological evaluation. , 2010, Journal of biomedical materials research. Part A.

[9]  Larry L Hench,et al.  Twenty-first century challenges for biomaterials , 2010, Journal of The Royal Society Interface.

[10]  Michael S. Detamore,et al.  Osteochondral Interface Tissue Engineering Using Macroscopic Gradients of Bioactive Signals , 2010, Annals of Biomedical Engineering.

[11]  Chun-hsien Wu,et al.  Effects of exogenous glycosaminoglycans on human chondrocytes cultivated on type II collagen scaffolds , 2010, Journal of materials science. Materials in medicine.

[12]  M. Detamore,et al.  Stress relaxation behavior of mandibular condylar cartilage under high-strain compression. , 2009, Journal of biomechanical engineering.

[13]  R. J. Ellis,et al.  Microsphere-based seamless scaffolds containing macroscopic gradients of encapsulated factors for tissue engineering. , 2008, Tissue engineering. Part C, Methods.

[14]  Yu-Chen Hu,et al.  Composite chondroitin-6-sulfate/dermatan sulfate/chitosan scaffolds for cartilage tissue engineering. , 2007, Biomaterials.

[15]  Ling Qin,et al.  Cartilage regeneration using mesenchymal stem cells and a PLGA-gelatin/chondroitin/hyaluronate hybrid scaffold. , 2006, Biomaterials.

[16]  M. McBurney,et al.  Poly(D,L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells. , 2004, Biomaterials.

[17]  David L. Cochran,et al.  Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies. , 2003, European cells & materials.

[18]  Dai Kato,et al.  The design of polymer microcarrier surfaces for enhanced cell growth. , 2003, Biomaterials.

[19]  Cato T Laurencin,et al.  Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro. , 2003, Journal of biomedical materials research. Part A.

[20]  D W Pack,et al.  Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[21]  L L Hench,et al.  Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. , 2001, Journal of biomedical materials research.

[22]  P. Ducheyne,et al.  New bioactive, degradable composite microspheres as tissue engineering substrates. , 2000, Journal of biomedical materials research.

[23]  W. O’Brien,et al.  Modified assay for determination of hydroxyproline in a tissue hydrolyzate. , 1980, Clinica chimica acta; international journal of clinical chemistry.

[24]  D. Huang.  Extracellular Matrix‐Cell Interactions and Chondrogenesis , 1977, Clinical orthopaedics and related research.

[25]  M. Detamore,et al.  Osteochondral interface regeneration of the rabbit knee with macroscopic gradients of bioactive signals. , 2012, Journal of biomedical materials research. Part A.

[26]  A. Boccaccini,et al.  Bioactive glass-based scaffolds for bone tissue engineering. , 2012, Advances in biochemical engineering/biotechnology.

[27]  Aaron M. Scurto,et al.  Microsphere-based scaffolds for cartilage tissue engineering: using subcritical CO(2) as a sintering agent. , 2010, Acta biomaterialia.

[28]  D. Deligianni,et al.  Effect of surface roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and detachment strength. , 2001, Biomaterials.